Naproxen

Naproxen Struktur
22204-53-1
CAS-Nr.
22204-53-1
Bezeichnung:
Naproxen
Englisch Name:
Naproxen
Synonyma:
NAPROXEN BASE;(S)-NAPROXEN;(S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid;Naprosyn;NAPROXENE;NAPROXEN FREE BASE;axer;Bonyl;Xenar;Naxen
CBNumber:
CB8274937
Summenformel:
C14H14O3
Molgewicht:
230.26
MOL-Datei:
22204-53-1.mol

Naproxen Eigenschaften

Schmelzpunkt:
152-154 °C (lit.)
alpha 
D +66° (in chloroform)
Siedepunkt:
332.25°C (rough estimate)
Dichte
1.1450 (rough estimate)
Brechungsindex
67.5 ° (C=1, CHCl3)
Flammpunkt:
9℃
storage temp. 
2-8°C
Löslichkeit
Practically insoluble in water, soluble in ethanol (96 per cent) and in methanol.
Aggregatzustand
powder
pka
pKa 4.28± 0.02(H2O,t =25,I=0.01) (Uncertain)
Farbe
White to Almost white
Optische Aktivität
[α]25/D +66°, c = 1 in chloroform
Wasserlöslichkeit
Insoluble in water.
Merck 
14,6417
BRN 
3591067
BCS Class
2
LogP
3.18
CAS Datenbank
22204-53-1(CAS DataBase Reference)
NIST chemische Informationen
Naproxen(22204-53-1)
EPA chemische Informationen
2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)- (22204-53-1)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn,T,F
R-Sätze: 22-39/23/24/25-23/24/25-11-36/37/38
S-Sätze: 36/37-45-16-7-26
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS-Nr. UF5275000
HazardClass  6.1(b)
PackingGroup  III
HS Code  29189900
Giftige Stoffe Daten 22204-53-1(Hazardous Substances Data)
Toxizität LD50 in mice (mg/kg): 435 i.v.; 1234 orally; in rats (mg/kg): 575 i.p.; 534 orally (Roszkowski)
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictogramsGHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
H411 Giftig für Wasserorganismen, mit langfristiger Wirkung. Langfristig (chronisch) gewässergefährdend Kategorie 2
Sicherheit
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P273 Freisetzung in die Umwelt vermeiden.
P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P302+P352 BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Naproxen Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R22:Gesundheitsschädlich beim Verschlucken.

S-Sätze Betriebsanweisung:

S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.

Beschreibung

Naproxen is synthesized from 2-methoxynaphthalene and the (+)-isomer obtained by resolution with cinchonidine (61). It was introduced in the United States in 1976 and, as a generic drug, has consistently been among the more popular NSAIDs. It is marketed as the S-(+)-enantiomer, but interestingly, the sodium salt of the (–)-isomer also is on the market as Anaprox. As an inhibitor of prostaglandin biosynthesis, it is 12 times more potent than aspirin, 10 times more potent than phenylbutazone, three to four times more potent than ibuprofen, and four times times more potent than fenoprofen, but it is approximately 300 times less potent than indomethacin.

Chemische Eigenschaften

white to light yellow crystal powde

Verwenden

Being analogous to other drugs of this series, naproxene exhibits analgesic, fever-reducing, and long-lasting anti-inflammatory action. It causes reduction and removal of painful symptoms including joint pain, stiffness, and swelling in the joints. It is used in the same indications as ibuprofen.

Definition

ChEBI: A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such a osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes.

Indications

Naproxen (Naprosyn) also has pharmacological properties and clinical uses similar to those of ibuprofen. It exhibits approximately equal selectivity for COX-1 and COX-2 and is better tolerated than certain NSAIDs, such as indomethacin. Adverse reactions related to the GI tract occur in about 14% of all patients, and severe GI bleeding has been reported. CNS complaints (headache, dizziness, drowsiness), dermatological effects (pruritus, skin eruptions, echinoses), tinnitus, edema, and dyspnea also occur.

Allgemeine Beschreibung

Naproxen (Naprosyn, Anaprox), marketed as the (S)-enantiomer,is well absorbed after oral administration, givingpeak plasma levels in 2 to 4 hours and a half-life of 13 hours.Naproxen is highly protein bound and displaces most protein-bound drugs. It is recommended for use in RA, OA, acute gouty inflammation, and in primary dysmenorrhea. Itshows good analgesic activity (i.e., 400 mg is comparable to75–150 mg of oral meperidine and superior to 65 mg ofpropoxyphene and 325 mg of aspirin plus 30 mg of codeine).It is also available OTC as 200-mg tablets (Aleve).

Pharmakokinetik

Naproxen is almost completely absorbed following oral administration. Peak plasma levels are achieved within 2 to 4 hours following administration. Like most of the acidic NSAIDs (pKa = 4.2), it is highly bound (99.6%) to plasma proteins. Approximately 70% of an administered dose is eliminated as either unchanged drug (60%) or as conjugates of unchanged drug (10%). The remainder is converted to the 6-O-desmethyl metabolite by both CYP3A4 and CYP1A2 and, further, to the glucuronide conjugate of the demethylated metabolite. The 6-O-desmethyl metabolite lacks anti-inflammatory activity. Like most of the arylalkanoic acids, the most common side effect associated with the use of naproxen is irritation to the GI tract. The most common other adverse reactions are associated with CNS disturbances (e.g., nausea and dizziness).

Clinical Use

Naproxen is indicated for the treatment of rheumatoid arthritis, osteoarthritis, juvenile arthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, and primary dysmenorrhea and for the relief of mild to moderate pain.

Nebenwirkungen

Common side effects of Naproxen may include indigestion, heartburn, stomach pain, nausea, headache, dizziness, drowsiness, bruising, itching, rash, swelling, or ringing in the ears. Seek immediate medical attention if you have any of the following serious drug reactions. For example: shortness of breath, swelling or rapid weight gain, rash, signs of stomach bleeding (bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds), liver problems (nausea, upper stomach pain, itching, feeling tired, flu-like symptoms, loss of appetite, dark urine, clay-coloured stools, jaundice), kidney problems (little or no urination, pain or difficulty in urinating, swelling of the feet or ankles, feeling tired or shortness of breath), low red blood cells (anaemia), etc. In addition, in rare cases, a severe allergic reaction to naproxen may occur. You may also suffer from stomach ulcers and other adverse reactions when taking it for a long time.

Naproxen Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Naproxen Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 708)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hpets Biotech Company (Chongqing) Co.,ltd
+8613340353813
info@hanpets.com China 26 58
Changzhou Rokechem Technology Co., Ltd.
18758118018
sales001@rokechem.com China 255 58
Wuhan Marco Pharmaceutical Technology Co., Ltd.
+86-86-18572802410 +8618572802410
sales@marcopht.com China 55 58
Shanghai Affida new material science and technology center
+undefined15081010295
2691956269@qq.com China 359 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618740459177
sarah@tnjone.com China 900 58
Ouhuang Engineering Materials (Hubei) Co., Ltd
+8617702722807
admin@hbouhuang.com China 2642 58
Henan Suikang Pharmaceutical Co.,Ltd.
+86-18239973690 +86-18239973690
sales@suikangpharm.com China 179 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497
sales01@cooperate-pharm.com CHINA 1811 55
Hefei TNJ Chemical Industry Co.,Ltd.
+86-0551-65418679 +86-18949832763
info@tnjchem.com China 2989 55

22204-53-1(Naproxen)Verwandte Suche:


  • ()-2-(methoxy-2-naphthyl)-propionicacid
  • ()-2-(methoxy-2-naphthyl)-propionsaeure
  • ()-propionicaci
  • (+)-2-(Methoxy-2-naphthyl)-propionic acid
  • (+)-2-(methoxy-2-naphthyl)-propionicacid
  • (+)-2-(Methoxy-2-naphthyl)-propionsaeure
  • (+)-2-naphthaleneaceticaci
  • (+)-6-Methoxy-alpha-methyl-2-napthaleneacetic acid
  • (s)-2-naphthaleneaceticaci
  • 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)-
  • 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)-
  • 6-Methoxy-methyl-2-naphthaleneaceticacid
  • axer
  • Bonyl
  • calosen
  • CG 3117
  • cg3117
  • Prexan
  • primeral
  • Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)-
  • Proxen
  • Proxine
  • Reuxen
  • RS-3540
  • Veradol
  • Xenar
  • (S)-6-Methoxy-α-methyl-2-naphthaleneacetic Acid
  • (dl)-propionic acid
  • Naproxen (base and/or unspecified salts)
  • (+)-2-(6-Methoxy-2-naphthyl)-propionic acid
  • (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid, (S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid
  • (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid, Naproxen, (S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid
  • (1)-2-(6-Methoxy-2-naphthyl)propionic acid
  • Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-
  • (+)-(S)-2-(6-METHOXYNAPTHALENE-2-YL)PROPIONIC ACID
  • (S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid,(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid, Naproxen
  • Naproxen (200 mg)
  • (2S)-2-(6-Methoxynaphth-2-yl)propanoic acid
  • Naproxen (INN)
  • Aproxen
  • po-Naproxen
  • Xenar-CR
  • Naproxen API
  • (S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid Naproxen
  • (S)-(+)-6-Methoxy-α-Methyl-2-naphthaleneacetic
  • d-2-(6’-methoxy-2’-naphthyl)-propionsaeure
  • d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure
  • Diocodal
  • (+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid~Naproxen
  • NAPROXEN USP /BP2000
  • Naproxen USP,BP.CP
  • (S)-6-METHOXY-A-METHYL-2-*NAPHTHALENEACE TIC ACID FR
  • NAPROXEN, FREE ACID, USP
  • NAPROXEN VETRANAL, 250 MG
  • Naprosyn[R]
  • 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)-
  • (+)-6-methoxy-à-methyl-2-naphthaleneacetic acid
  • (2R)-2-(6-methoxynaphthalen-2-yl)propanoic acid
Copyright 2019 © ChemicalBook. All rights reserved